Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/19/2010CN101129798B Medical ointment for treating chronic atrophic gastritis by plastering and applying on acupuncture point
05/19/2010CN101129698B Eye drops containing turmeric extractive and preparation method thereof
05/19/2010CN101125135B Artemether cataplasma and its application
05/19/2010CN101125127B Artemisinin derivatives freeze-dried preparation and preparation method
05/19/2010CN101121739B Hydrolysable tannin and application thereof
05/19/2010CN101121738B 1,3-O-di-galloyl-6-O-(S)-decapetalous caesalpinia acyl-beta-D-glucopyranose and application thereof
05/19/2010CN101121737B Novel hydrolysable tannin and application thereof
05/19/2010CN101116664B Application of compound 1-( 4-chloroaniline )-4-( 4-picoline )-2, 3-naphthyridine
05/19/2010CN101116661B Application of 5-hydroxymethyl furfural in the preparation of medicine for protecting vascellum endothelial cell
05/19/2010CN101112504B Chinese medicine for curing cancer and the method for preparing the oral liquid thereof
05/19/2010CN101112459B Smelly phoenix tree extract, method for preparing the same and use thereof
05/19/2010CN101112429B Medicine for treating hemorrhage and fin rot of aquatic animals
05/19/2010CN101108184B Liranaftate complex medicament and method of preparing the same
05/19/2010CN101104065B Traditional Chinese medicine preparation for preventing respiratory viral infection disease and preparation method
05/19/2010CN101103036B Artemisine (Qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same
05/19/2010CN101102769B Synthesis of sodium narcistatin and related compounds
05/19/2010CN101095956B Scutellarin prodrug using carboxymethyl chitosan as the carrier and method for preparing the same
05/19/2010CN101095786B Hyperplasia hernia ion rehabilitating ointment and method for preparing the same
05/19/2010CN101095764B Health-care food having assisted function of treating female urinary tract taint
05/19/2010CN101095708B Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating systematic lupus erythematosus
05/19/2010CN101095673B Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone
05/19/2010CN101089008B Dicyclic analog without ring A and ring B of omithogalum caudatum OSW-1 saponin and its synthesis process and use
05/19/2010CN101088517B Process of making sweel cool health myrobalan fruit
05/19/2010CN101085181B Plaster for treating bony spur and osteoproliferation and preparation method thereof
05/19/2010CN101074190B Alpha-substituted 3,5-bisubsituted acrylic acid and its derivative, preparation and use
05/19/2010CN101066459B Polyesthylene glycol modified zidovudine conjugate and its preparation process and application
05/19/2010CN101066278B Medicine use of energy mixture
05/19/2010CN101066263B Use of baicalein as antifungal medicine synergist
05/19/2010CN101062029B Application of wogonin in the preparing of medicine for treating gastric cancer
05/19/2010CN101049337B Medication for curing furuncle, sore, and carbuncle, and preparation method
05/19/2010CN101040919B Chinese traditional medicine for treating cholecystitis
05/19/2010CN101040912B Chinese traditional medicine capsule preparation for resisting radiation and improving immunity, and the method for preparing the same
05/19/2010CN101040896B Flavone of astragalus extract, the medicine use and the compound thereof
05/19/2010CN101040894B Preparing and application of Yulangsan extract
05/19/2010CN101040848B Method for preparing amphiphilic nanoparticles
05/19/2010CN101037688B Small molecule interfering RNA and its anti-tumor use
05/19/2010CN101036691B Health-caring product for improving bone density and immunity
05/19/2010CN101033226B 1-furylmethyl-3-substituted indolin-2-one derivative
05/19/2010CN101029069B Kaide glycoside 3-O-beta-Cima glycoside in white fleece-flower root and its use
05/19/2010CN101029065B Bean-curd pectin analogue and its use in medicine for preventing depression
05/19/2010CN101028254B Sustaining agent of Duosuo theosine and its preparation
05/19/2010CN101028251B Camptothecine derivative phosphatide composite liposome nano-preparation and its making method
05/19/2010CN101024665B Decarboxylated FR-008 derivative polyketone antibiotic and use thereof
05/19/2010CN101020028B Chinese medicine for treating cardiac and cerebral vascular diseases
05/19/2010CN101019938B Chinese medicine for treating enteritis and colitis and its preparation method
05/19/2010CN101012210B Taxone derivatives, preparing method and pharmaceutical use thereof
05/19/2010CN101011543B Antineoplastic medicine composition
05/19/2010CN101007009B A drug for preventing and treating liver injury and lowering blood fat
05/19/2010CN101006984B An injection preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application
05/19/2010CN101006975B An oral medicine preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application
05/19/2010CN101003550B 8- halogenated adenine nucleotide compound , synthetic method, medical application
05/19/2010CN101002874B Compound traditional Chinese medicine with antibiotic and anti-inflammatory function, and its preparing method
05/19/2010CN101002782B Medicine composition containing ceftin cyclodextrin clathrate, and its preparing method
05/19/2010CN100998592B Microemulsion containing matrine
05/18/2010USRE41339 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
05/18/2010US7718830 5-Chloro-4-(6-Isopropenyl-3-methylcyclohex-2-enyl)benzene-1,3-diol; glaucoma or ocular hypertension
05/18/2010US7718824 Therapeutic stem cell growth factor composition, anti-inflammatory composition, and uses thereof
05/18/2010US7718815 Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
05/18/2010US7718813 Such as isoflavones, phytoestrogens, sitosterols and saponins from soy for use in a dermatological or cosmetic preparation; hydrolysis in acidic solution, adding water to precipitate, followed by solvent extraction steps in alcohol and organic solvent
05/18/2010US7718809 Such as 4-[(7-fluoro-3,4-dihydro-2H-chromen-4yl)oxy]-N,N,1,2-tetramethyl-1H-benzimidazole-6-carboxamide; gastrointestinal and airway disorders; metabolically stable, pharmacokinetics, nontoxic; nonhygroscopic, easily formulated
05/18/2010US7718808 adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders
05/18/2010US7718804 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors
05/18/2010US7718802 Substituted melanocortin receptor-specific piperazine compounds
05/18/2010US7718797 Fasudil-containing preparation and method of improving stability thereof
05/18/2010US7718795 Succinoylamino benzodiazepines as inhibitors of aβ protein production
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718782 Charged sophorolipids and sophorolipid containing compounds
05/18/2010US7718746 Anion-binding polymers and uses thereof
05/18/2010US7718715 pH-modified latex comprising a synergistic combination of biocides
05/18/2010US7718705 administering on an as-needed basis to the mammal a therapeutically effective amount of dapoxetin or salt to a male human to treat sexual dysfunction e.g. premature ejaculation
05/18/2010US7718704 Immunosuppressant compounds and compositions
05/18/2010US7718703 Norvaline derivative and method for preparation thereof
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718701 Prostaglandin, e.g., 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acids; treating in particular, symptoms of atopic dermatitis
05/18/2010US7718700 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors, angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents
05/18/2010US7718699 Abscissic acid and derivatives thereof for the treatment of diseases
05/18/2010US7718698 Adding fatty acid ester, a fatty acid amide, a free fatty acid or a hydrocarbon, to a mixture of a fat or an oil, being edible or for use in cosmetics; stripping and separating the environmental pollutant present in the fat or oil
05/18/2010US7718697 Method for treating glaucoma comprising administering α-lipoic acid
05/18/2010US7718696 Methods of treating diabetes using carnitine conjugates as dual prodrugs
05/18/2010US7718695 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
05/18/2010US7718694 Compositions and methods for therapy for diseases characterized by defective chloride transport
05/18/2010US7718693 N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide; modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor; treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration
05/18/2010US7718692 or antipyretics; use of N-heterocyclecarboxylic acid, p-hydroxyphenyl amides or N-(p-hydroxyphenyl)-2-thio-group substituted acetamides; e.g. Pyrrolidine-2-carboxylic acid (p-hydroxyphenyl)-amide; substitute for aspirin in upper GI disease, aspirin allergy, bleeding disorders, clients on anticoagulants
05/18/2010US7718691 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
05/18/2010US7718690 e.g. [2-(1-(Benzenesulfonyl)-1H-indol-3-yloxy)ethyl]dimethylamine; serotonin, melatonin receptor ligand; antidepressant, anxiolytic agent; cognition activator; psychosis, schizophrenia, migraine headache, drug addiction, convulsions, osteoporosis, ischemic stroke, Alzheimer's, Parkinson's diseases
05/18/2010US7718689 Benzoisoindole derivatives and their use as EP4 receptor ligands
05/18/2010US7718688 as hypoxia-selective drugs and radiosensitizers for cancer therapy; nitroreductase inhibitor; 1-(Chloromethyl)-5,6-dinitro-3-(5,6,7-trimethoxyindol-2-carbonyl)-1,2-dihydro-3H-benzo[e]indole; halogenation of naphthalene derivative followed by hydration and cyclization
05/18/2010US7718687 Dihydropyrrole derivatives; 3-{(2S)-4-(2,5-difluorophenyl)-1-[(dimethylamino)carbonyl]-2,5-dihydro- 1H-pyrrol-2-yl}phenyl dihydrogen phosphate; anticarcinogenic agents; cellular proliferative diseases; specificity; side effect reduction
05/18/2010US7718686 Gastrointestinal disorders; irritable bowel syndrome
05/18/2010US7718684 Methods and materials for assessing prostate cancer therapies and compounds
05/18/2010US7718683 Triazolyl phenyl benzenesulfonamides
05/18/2010US7718682 3-(3,5-Dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylamide useful for therapy of inflammation, inflammatory bowl disease, psoriasis, rheumatic arthritis, dematitis and cardiovascular disorders; inhibiting the activity of TNF-alpha, IL-1, IL-6, or COX
05/18/2010US7718681 CDC25B phosphatase inhibitors; side effect reduction; Vilsmeier-Haack reaction; alkenylation reaction of thiazolo-2,4-dione; methenylation reaction using acetophenone derivative
05/18/2010US7718680 administering e.g. 5-[5-(1-trifluoromethyl-4-Chloro-phenyl)-furan-2-ylmethylidene]-4-oxo-2-thioxo-thiazolidin-3-yl}-acetic acid as a bactericide to inhibit lethal factor (LF) protease activity of anthrax toxin
05/18/2010US7718679 Heteroaryl carboxamides
05/18/2010US7718678 diamino-substituted 1,2,5-oxadiazoles for treatment of cancer, gingivitis, antiatherosclerosis, as viricide, aniinflammatory agent, antiogenesis inhibitor and analgesic
05/18/2010US7718677 Including nicotinic receptor agonist to suppress dyskinesia impact of dopaminergic agent; Parkinson's disease management
05/18/2010US7718676 E.g., Methyl 4-{[4-Methyl-3-(4-pyridin-3-yl-oxazol-2-ylamino)-phenylamino]-methyl}-benzoate; stem cell factor, bcr-abl, fibroblastic growth factor receptor-3 and Flt-3 inhibitors; treating rheumatoid arthritis, conjunctivitis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, transplant rejection
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718674 Nerve membrane stabiizers; inducing local, topical or dermal anesthesia